Basic Information
ID: ALA4316441
Type: Functional
Description: Antiviral activity against VSV-G pseudotyped HIV1 transfected in human 293T cells co-transfected with NL4-3 HIV1 supernatant infected in human SupT1 cells treated with compound for 48 hrs assessed as inhibition of viral infection at 10 uM after 48 hrs by luciferase assay (Rvb = 0 %)
Organism: Human immunodeficiency virus 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4316441
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 547.67 | 2.38 | 2.38 |
| 561.64 | 0.69 | 0.69 |
| 542.66 | 1.69 | 1.69 |
| 558.66 | 0.98 | 0.98 |
| 576.65 | 1.12 | 1.12 |
| 557.67 | 0.86 | 0.86 |
| 591.62 | 1.02 | 1.02 |
| 572.68 | 1.29 | 1.29 |
| 588.68 | 0.47 | 0.47 |
| 573.63 | 0.88 | 0.88 |
| 543.65 | 0.55 | 0.55 |
| 557.67 | 1.27 | 1.27 |